ANDHealth Helps Digital Health Startups Turn Ideas into Patient Solutions
24 Mar 2026
Digital health includes things like wearable sensors, AI diagnostics, connected devices, precision genomics, and digital therapeutics. According to Ms Bronwyn Le Grice, CEO of ANDHealth, these technologies have the potential to transform healthcare in Australia and around the world.
Supporting the digital health ecosystem
Founded in 2017, ANDHealth helps companies overcome the unique challenges of digital health commercialisation. The organisation provides access to mentoring, training, one-to-one support, non-dilutive funding, and international market opportunities.
At a sector level, ANDHealth supports clinical trials, job creation, investment, regulatory approvals, and patient impact.
Growing startups through ANDHealth+
The Medical Research Future Fund (MRFF) funds the ANDHealth+ program, which supports small and medium enterprises with proof-of-concept digital health products. Companies in the program receive a support team and advisory panel of industry leaders, consumers, and community representatives. They follow a project plan with milestones to help their product become market ready.
One success story is Navier Medical, based in Western Australia. Their platform, Mosaic, analyses heart CT scans using AI to detect high-risk cardiovascular disease. Since joining ANDHealth+ in April 2024, Mosaic V1 received FDA clearance in June 2025, a major step toward commercialisation.
Staying Australian while going global
Digital health software can scale globally without the manufacturing challenges of other medical products. ANDHealth supports companies to “grow locally and scale globally”, keeping jobs and research in Australia where possible.
Advice for innovators
Bronwyn encourages early-stage digital health entrepreneurs to seek advice, connect with experts, and be resilient. She says, “If things don’t go as planned, reflect, redesign, and pivot. Stay focused on your end goal.”
https://www.health.gov.au/
Source: ANDHealth